- Home
- TOVX vs AMIX Comparison
TOVX vs AMIX Comparison
Compare TOVX & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- AMIX
- Stock Information
- Founded
- TOVX 2001
- AMIX 2014
- Country
- TOVX United States
- AMIX United States
- Employees
- TOVX N/A
- AMIX N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- TOVX Health Care
- AMIX
- Exchange
- TOVX Nasdaq
- AMIX NYSE
- Market Cap
- TOVX 4.7M
- AMIX 5.5M
- IPO Year
- TOVX 2006
- AMIX N/A
- Fundamental
- Price
- TOVX $1.18
- AMIX $1.67
- Analyst Decision
- TOVX Strong Buy
- AMIX
- Analyst Count
- TOVX 1
- AMIX 0
- Target Price
- TOVX $6.00
- AMIX N/A
- AVG Volume (30 Days)
- TOVX 23.5K
- AMIX 41.1K
- Earning Date
- TOVX 05-06-2025
- AMIX 02-13-2025
- Dividend Yield
- TOVX N/A
- AMIX N/A
- EPS Growth
- TOVX N/A
- AMIX N/A
- EPS
- TOVX N/A
- AMIX N/A
- Revenue
- TOVX N/A
- AMIX N/A
- Revenue This Year
- TOVX N/A
- AMIX N/A
- Revenue Next Year
- TOVX N/A
- AMIX N/A
- P/E Ratio
- TOVX N/A
- AMIX N/A
- Revenue Growth
- TOVX N/A
- AMIX N/A
- 52 Week Low
- TOVX $1.03
- AMIX $1.52
- 52 Week High
- TOVX $12.25
- AMIX $75.80
- Technical
- Relative Strength Index (RSI)
- TOVX 44.04
- AMIX 31.56
- Support Level
- TOVX $1.08
- AMIX $1.52
- Resistance Level
- TOVX $1.21
- AMIX $2.11
- Average True Range (ATR)
- TOVX 0.07
- AMIX 0.17
- MACD
- TOVX 0.00
- AMIX -0.00
- Stochastic Oscillator
- TOVX 57.89
- AMIX 20.55
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.